Advisory Bodies

Through our advisory bodies,  Canada’s Drug Agency is able to enlist the support of experts from across the country to inform our work. These bodies also facilitate the exchange of health technology information within Canada.  For enquiries or requests for assistance related to our committees, please contact [email protected].

Committees and working groups that provide strategic advice:

• Appropriate Use Advisory Committee (AUAC)
• Patient and Community Advisory Committee (PCAC)
• Pharmaceutical Advisory Committee Formulary Working Group for Health Technology Assessments
• Pharmaceutical Advisory Committee
• Pharmaceutical Advisory Committee Formulary Working Group (FWG)
• Provincial Advisory Group (PAG)
• Post-Market Drug Evaluation Advisory Committee